ArticleWorld journal of surgical oncology2022

STMN1 as a novel prognostic biomarker in HCC correlating with immune infiltrates and methylation.

En-di Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.